Objective:
To describe outcomes of people admitted to hospital with coronavirus disease 2019 (covid-19) in the United States, and the clinical and laboratory characteristics associated with severity of illness.
Design:
Prospective cohort study.
Setting:
Single academic medical center in New York City and Long Island.
Participants:
5279 patients with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection between 1 March 2020 and 8 April 2020. The final date of follow up was 5 May 2020.
Main Outcome Measures:
Outcomes were admission to hospital, critical illness (intensive care, mechanical ventilation, discharge to hospice care, or death), and discharge to hospice care or death. Predictors included patient characteristics, medical history, vital signs, and laboratory results. Multivariable logistic regression was conducted to identify risk factors for adverse outcomes, and competing risk survival analysis for mortality.
Results:
Of 11 544 people tested for SARS-Cov-2, 5566 (48.2%) were positive. After exclusions, 5279 were included. 2741 of these 5279 (51.9%) were admitted to hospital, of whom 1904 (69.5%) were discharged alive without hospice care and 665 (24.3%) were discharged to hospice care or died. Of 647 (23.6%) patients requiring mechanical ventilation, 391 (60.4%) died and 170 (26.2%) were extubated or discharged. The strongest risk for hospital admission was associated with age, with an odds ratio of >2 for all age groups older than 44 years and 37.9 (95% confidence interval 26.1 to 56.0) for ages 75 years and older. Other risks were heart failure (4.4, 2.6 to 8.0), male sex (2.8, 2.4 to 3.2), chronic kidney disease (2.6, 1.9 to 3.6), and any increase in body mass index (BMI) (eg, for BMI >40: 2.5, 1.8 to 3.4). The strongest risks for critical illness besides age were associated with heart failure (1.9, 1.4 to 2.5), BMI >40 (1.5, 1.0 to 2.2), and male sex (1.5, 1.3 to 1.8). Admission oxygen saturation of <88% (3.7, 2.8 to 4.8), troponin level >1 (4.8, 2.1 to 10.9), C reactive protein level >200 (5.1, 2.8 to 9.2), and D-dimer level >2500 (3.9, 2.6 to 6.0) were, however, more strongly associated with critical illness than age or comorbidities. Risk of critical illness decreased significantly over the study period. Similar associations were found for mortality alone.
Conclusions:
Age and comorbidities were found to be strong predictors of hospital admission and to a lesser extent of critical illness and mortality in people with covid-19; however, impairment of oxygen on admission and markers of inflammation were most strongly associated with critical illness and mortality. Outcomes seem to be improving over time, potentially suggesting improvements in care.
Citing Articles
Geographic inequalities and factors associated with unfavorable outcomes in diabetes-tuberculosis and diabetes-covid comorbidities in Brazil.
Alves L, Berra T, Alves Y, Ferezin L, Vinci A, Tavares R
Sci Rep. 2025; 15(1):8353.
PMID: 40069306
PMC: 11897301.
DOI: 10.1038/s41598-025-93476-6.
Identifying and Validating Prognostic Hyper-Inflammatory and Hypo-Inflammatory COVID-19 Clinical Phenotypes Using Machine Learning Methods.
Ji X, Guo Y, Tang L, Gao C
J Inflamm Res. 2025; 18:3009-3024.
PMID: 40034687
PMC: 11874972.
DOI: 10.2147/JIR.S504028.
Use of Different Inclusion Criteria to Compare COVID-19 Hospital Admission Rates by Race and Ethnicity: A Cohort Study.
Longcoy J, Isgor Z, Suzuki S, Lynch E, Wang H, Ansell D
Healthcare (Basel). 2025; 13(4).
PMID: 39997256
PMC: 11855206.
DOI: 10.3390/healthcare13040381.
Biomarker states and risk of death among individuals hospitalized with SARS-CoV-2 infection.
Thaweethai T, Selvaggi C, Ng T, Cheng D, Cao T, Chibnik L
BMC Infect Dis. 2025; 25(1):260.
PMID: 39994606
PMC: 11849268.
DOI: 10.1186/s12879-025-10651-w.
Determinants of SARS-CoV-2 infection across three sentinels sites in Benin during 2021: A multicentric surveillance study.
Atchade A, Yadouleton A, Fiogbe M, Abdoulaye Alfa D, Yovo E, Le Hesran J
PLOS Glob Public Health. 2025; 5(2):e0004227.
PMID: 39946403
PMC: 11824965.
DOI: 10.1371/journal.pgph.0004227.
The changing demographics and severity in hospitalized patients across COVID-19 variants: A national cohort study.
Parajuli P, Phipps L, Sabo R, Alsaadawi R, Robinson A, French E
J Clin Transl Sci. 2025; 9(1):e22.
PMID: 39911936
PMC: 11795861.
DOI: 10.1017/cts.2024.1166.
Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave.
La Y, Oh W, Kim C, Lim M, Jeon Y
BMC Infect Dis. 2025; 25(1):167.
PMID: 39910500
PMC: 11796008.
DOI: 10.1186/s12879-025-10585-3.
ACCREDIT: Validation of clinical score for progression of COVID-19 while hospitalized.
Melo V, do Brasil P
Glob Epidemiol. 2025; 9():100181.
PMID: 39850445
PMC: 11754157.
DOI: 10.1016/j.gloepi.2024.100181.
Sex Differences in Long COVID.
Shah D, Thaweethai T, Karlson E, Bonilla H, Horne B, Mullington J
JAMA Netw Open. 2025; 8(1):e2455430.
PMID: 39841477
PMC: 11755195.
DOI: 10.1001/jamanetworkopen.2024.55430.
The Role of Age and Comorbidity Interactions in COVID-19 Mortality: Insights from Cardiac and Pulmonary Conditions.
Patrascu R, Dumitru C, Laza R, Besliu R, Gug M, Zara F
J Clin Med. 2025; 13(24.
PMID: 39768431
PMC: 11677844.
DOI: 10.3390/jcm13247510.
Predictors of high-flow nasal cannula (HFNC) failure in severe community-acquired pneumonia or COVID-19.
Grunewaldt A, Gaillard M, Rohde G
Intern Emerg Med. 2024; .
PMID: 39733203
DOI: 10.1007/s11739-024-03844-9.
Clinical characteristics and risk factors for in-hospital mortality of COVID-19 patients in Hubei Province: A multicenter retrospective study.
He W, Li G, Xu K, Yu B, Sun Y, Zhong K
Int J Cardiol Heart Vasc. 2024; 56:101574.
PMID: 39687686
PMC: 11648888.
DOI: 10.1016/j.ijcha.2024.101574.
Timing dilemma: a systematic review and meta-analysis of short-term mortality in patients with COVID-19 undergoing tracheostomy with varied timing, including 7, 10 and 14 days.
Kim B, Choi H, Kim C
BMJ Open. 2024; 14(12):e084405.
PMID: 39658285
PMC: 11647386.
DOI: 10.1136/bmjopen-2024-084405.
Diagnostic and Prognostic Value of SCUBE-1 in COVID-19 Patients.
Ozer V, Gonenc Cekic O, Bulbul O, Aydin D, Bulut E, Aksoy F
West J Emerg Med. 2024; 25(6):975-984.
PMID: 39625772
PMC: 11610722.
DOI: 10.5811/westjem.18586.
Clinical characteristics of adult asthma patients hospitalized by COVID-19 in Mexico City: a real-world study.
Lopez-Vinasco A, Montero-Vargas J, Garcia-Guillen M, De la Pena-Hernandez L, Teran L
Ann Med. 2024; 56(1):2424448.
PMID: 39623785
PMC: 11616761.
DOI: 10.1080/07853890.2024.2424448.
Significance of Initial Chest CT Severity Score (CTSS) and Patient Characteristics in Predicting Outcomes in Hospitalized COVID-19 Patients: A Single Center Study.
Milenkovic A, Nikolic S, Elek Z, Aritonovic Pribakovic J, Ilic A, Bulatovic K
Viruses. 2024; 16(11).
PMID: 39599799
PMC: 11599031.
DOI: 10.3390/v16111683.
Early Elevated Inflammatory Markers in SARS-CoV-2 Vaccinated Patients Are Associated with Reduced Mortality, Morbidity, and Lung Injury.
Khayat O, Basheer M, Derawy M, Assy N
Life (Basel). 2024; 14(11).
PMID: 39598212
PMC: 11595982.
DOI: 10.3390/life14111415.
Outpatient characteristics in a pediatric otolaryngology department during COVID-19 pandemic: A retrospective study.
Noda M, Koshu R, Sugimoto H, Yoshizaki T, Nomura A, Ito M
Sci Prog. 2024; 107(4):368504241301809.
PMID: 39574374
PMC: 11585036.
DOI: 10.1177/00368504241301809.
Identification of Novel Genomic Variants in COVID-19 Patients Using Whole-Exome Sequencing: Exploring the Plausible Targets of Functional Genomics.
Mir R, Altemani F, Altemani F, Algehainy N, Alanazi M, Elfaki I
Biochem Genet. 2024; .
PMID: 39557769
DOI: 10.1007/s10528-024-10970-8.
Proposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors.
Reddy K, Faridi K, Aggarwal M, Tirumalai A, Singh T, Tejtel K
Am J Lifestyle Med. 2024; :15598276241269532.
PMID: 39540176
PMC: 11556543.
DOI: 10.1177/15598276241269532.